EUVIMEDEUVIMED entdecken
Crossref

Design, synthesis of novel chromene‐based scaffolds targeting hepatocellular carcinoma: Cell cycle arrest, cytotoxic effect against resistant cancer cells, apoptosis induction, and c‐Src inhibition

Eman K A Abdelall, Heba A H Elshemy iD, Madlen B Labib iD, Fatma E A Mohamed

Drug Development Research · 2024

DOI: 10.1002/ddr.22133 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Development Research, 2024. Verfasst von Eman K A Abdelall und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Organic Chemistry, Faculty of Pharmacy, Beni-Suef University, Beni-Suef, Egypt. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Antineoplastic Agents. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 52 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

New chromene derivatives were synthesized based on 4‐(3,4‐dimethoxy)‐4 H ‐chromene scaffold. All target compounds exhibited cytotoxic activity against HepG2 cells (IC 50 = 2.40–141.22 μM). Chromens 5 and 9 showed superior cytotoxicity over staurosporine (IC 50 = 18.27 μM) and vinblastine (IC 50 = 5.20 μM). c‐Src kinase inhibition assay of compounds 5 and 9 displayed the dominant c‐Src inhibitory activity of 5 (IC 50 = 0.184 μM) over 9 (IC 50 = 0.288 μM). The safety of the most potent compound 5 against normal WI‐38 cells was confirmed via its IC 50 of 115.75 μM comparable with 5‐FU (IC 50 = 16.28 μM). Moreover, the promising chromene 5 displayed potent cytotoxicity against resistant HepG2 cells with IC 50 of 26.03 μM comparable with 5‐FU (IC 50 = 42.68 μM). The most active chromene 5 arrested the HepG2 cell cycle at the S phase and induced a 29‐fold increase in the total number of apoptotic cells indicating pre‐G1 apoptosis. The ability of compound 5 to induce apoptosis was supported via elevation of caspase‐3, caspase‐7, caspase‐9 and proapoptotic Bax protein levels in addition to downregulation of the antiapoptotic Bcl2 protein. Molecular docking studies of compound 5 showed good binding interaction pattern inside c‐Src kinase enzyme active site.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsAntineoplastic AgentsHumansMolecular StructureStructure-Activity RelationshipBenzopyransMolecular Docking SimulationCSK Tyrosine-Protein KinaseCell ProliferationDrug Screening Assays, AntitumorCell Cycle CheckpointsApoptosisFluorouracilDrug Design

Stichwörter der Autor:innen

HCCapoptosisc-Srccell cyclechromene

Substanzen

BenzopyransCSK Tyrosine-Protein KinaseAntineoplastic AgentsFluorouracil

Autor:innen und Institutionen

  • Department of Pharmaceutical Organic Chemistry, Faculty of Pharmacy, Beni-Suef University, Beni-Suef, Egypt.

ORCID-Profile: Heba A H Elshemy, Madlen B Labib

Zitieren

APA

Abdelall, E. K. A., Elshemy, H. A. H., Labib, M. B., & Mohamed, F. E. A. (2024). Design, synthesis of novel chromene‐based scaffolds targeting hepatocellular carcinoma: Cell cycle arrest, cytotoxic effect against resistant cancer cells, apoptosis induction, and c‐Src inhibition. Drug Development Research. https://doi.org/10.1002/ddr.22133

Vancouver

Abdelall EKA, Elshemy HAH, Labib MB, Mohamed FEA. Design, synthesis of novel chromene‐based scaffolds targeting hepatocellular carcinoma: Cell cycle arrest, cytotoxic effect against resistant cancer cells, apoptosis induction, and c‐Src inhibition. Drug Development Research. 2024. doi:10.1002/ddr.22133

BibTeX
@article{Abdelall2024,
  author = {Abdelall, Eman K A and Elshemy, Heba A H and Labib, Madlen B and Mohamed, Fatma E A},
  title = {Design, synthesis of novel chromene‐based scaffolds targeting hepatocellular carcinoma: Cell cycle arrest, cytotoxic effect against resistant cancer cells, apoptosis induction, and c‐Src inhibition},
  journal = {Drug Development Research},
  year = {2024},
  doi = {10.1002/ddr.22133}
}
Kostenlos starten →